BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20236292)

  • 1. Neuroendocrine ductal carcinoma in situ of the breast: cytological features in 32 cases.
    Kawasaki T; Nakamura S; Sakamoto G; Kondo T; Tsunoda-Shimizu H; Ishii Y; Nakazawa T; Mochizuki K; Yamane T; Inoue M; Inoue S; Katoh R
    Cytopathology; 2011 Feb; 22(1):43-9. PubMed ID: 20236292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine ductal carcinoma in situ (NE-DCIS) of the breast--comparative clinicopathological study of 20 NE-DCIS cases and 274 non-NE-DCIS cases.
    Kawasaki T; Nakamura S; Sakamoto G; Murata S; Tsunoda-Shimizu H; Suzuki K; Takahashi O; Nakazawa T; Kondo T; Katoh R
    Histopathology; 2008 Sep; 53(3):288-98. PubMed ID: 18657193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ.
    Rosen EL; Smith-Foley SA; DeMartini WB; Eby PR; Peacock S; Lehman CD
    Breast J; 2007; 13(6):545-50. PubMed ID: 17983393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
    Bofin AM; Lydersen S; Hagmar BM
    Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine needle aspiration cytology of neuroendocrine carcinoma of the breast--a case report and review of literature.
    Kadir AA; Iyengar KR; Peh SC; Yip CH
    Malays J Pathol; 2008 Jun; 30(1):57-61. PubMed ID: 19108413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fine-needle aspiration cytology of breast carcinoma with endocrine differentiation.
    Tse GM; Ma TK
    Cancer; 2000 Oct; 90(5):286-91. PubMed ID: 11038425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between type and grade of ductal carcinoma in situ and concomitant invasive ductal carcinoma of the breast.
    Rudnicka L; Stachura J
    Pol J Pathol; 2000; 51(3):137-43. PubMed ID: 11247396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flat epithelial atypia and atypical ductal hyperplasia: carcinoma underestimation rate.
    Ingegnoli A; d'Aloia C; Frattaruolo A; Pallavera L; Martella E; Crisi G; Zompatori M
    Breast J; 2010; 16(1):55-9. PubMed ID: 19825003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of ductal carcinoma in situ of the breast.
    Yoshida M; Kinoshita T
    Jpn J Clin Oncol; 2009 Feb; 39(2):132. PubMed ID: 19155284
    [No Abstract]   [Full Text] [Related]  

  • 10. [Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings].
    Piubello Q; Montemezzi S; D'Atri C
    Pathologica; 2002 Dec; 94(6):299-305. PubMed ID: 12540993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ductal carcinoma in situ in dynamic MR-mammography at 1.5 T].
    Fischer U; Westerhof JP; Brinck U; Korabiowska M; Schauer A; Grabbe E
    Rofo; 1996 Apr; 164(4):290-4. PubMed ID: 8645861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine needle aspiration cytology of breast ductal carcinoma in situ.
    Venegas R; Rutgers JL; Cameron BL; Vargas H; Butler JA
    Acta Cytol; 1994; 38(2):136-43. PubMed ID: 8147202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of ductal carcinoma in situ in magnetic resonance imaging.
    Facius M; Renz DM; Neubauer H; Böttcher J; Gajda M; Camara O; Kaiser WA
    Clin Imaging; 2007; 31(6):394-400. PubMed ID: 17996602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Morphology and contrast enhancement of ductal carcinoma in situ in dynamic 1.0 T MR mammography].
    Sittek H; Kessler M; Heuck AF; Bredl T; Perlet C; Künzer I; Lebeau A; Untch M; Reiser M
    Rofo; 1997 Sep; 167(3):247-51. PubMed ID: 9376552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In situ ductal carcinoma of the breast].
    Peña-Estévez VL; Aguilar U; Torrescano Granillo A
    Ginecol Obstet Mex; 1999 Feb; 67():43-9. PubMed ID: 10327763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of fine-needle aspiration cytology and core biopsy in the diagnosis of proliferative and atypical breast lesions.
    Maygarden SJ
    Anat Pathol; 1997; 2():165-96. PubMed ID: 9575375
    [No Abstract]   [Full Text] [Related]  

  • 17. MR imaging of ductal carcinoma in situ.
    Orel SG; Mendonca MH; Reynolds C; Schnall MD; Solin LJ; Sullivan DC
    Radiology; 1997 Feb; 202(2):413-20. PubMed ID: 9015067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Columnar cell lesions: fine-needle aspiration biopsy features.
    Saqi A; Mazziotta R; Hamele-Bena D
    Diagn Cytopathol; 2004 Dec; 31(6):370-5. PubMed ID: 15540173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic characteristics of ductal carcinoma in situ (DCIS) in dynamic breast MRI using computer-assisted analysis.
    Vag T; Baltzer PA; Dietzel M; Benndorf M; Gajda M; Camara O; Kaiser WA
    Acta Radiol; 2010 Nov; 51(9):955-61. PubMed ID: 20942728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion-weighted imaging in breast cancer: relationship between apparent diffusion coefficient and tumour aggressiveness.
    Costantini M; Belli P; Rinaldi P; Bufi E; Giardina G; Franceschini G; Petrone G; Bonomo L
    Clin Radiol; 2010 Dec; 65(12):1005-12. PubMed ID: 21070905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.